Alene Kennedy-Hendricks1, Susan H Busch2, Emma E McGinty3, Marcus A Bachhuber4, Jeff Niederdeppe5, Sarah E Gollust6, Daniel W Webster7, David A Fiellin8, Colleen L Barry9. 1. Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, 624 N. Broadway, Baltimore, MD 21205, United States. Electronic address: alene@jhu.edu. 2. Department of Health Policy and Management, Yale School of Public Health, 60 College Street, New Haven, CT 06520, United States. 3. Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, 624 N. Broadway, Baltimore, MD 21205, United States; Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, 624 N. Broadway, Baltimore, MD 21205, United States; Johns Hopkins Center for Injury Research and Policy, Johns Hopkins Bloomberg School of Public Health, 624 N. Broadway, Baltimore, MD 21205, United States. 4. Division of General Internal Medicine, Department of Medicine, Montefiore Medical Center/Albert Einstein College of Medicine, 3300 Kossuth Avenue, Bronx, NY 10467, United States. 5. Department of Communication, Cornell University, 328 Kennedy Hall, Ithaca, NY 14853, United States. 6. Division of Health Policy and Management, University of Minnesota School of Public Health, 420 Delaware Street SE, 15-230 PWB, Minneapolis, MN 55455, United States. 7. Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, 624 N. Broadway, Baltimore, MD 21205, United States; Johns Hopkins Center for Injury Research and Policy, Johns Hopkins Bloomberg School of Public Health, 624 N. Broadway, Baltimore, MD 21205, United States. 8. Department of Internal Medicine, Yale School of Medicine, 333 Cedar Street, New Haven, CT 06520, United States. 9. Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, 624 N. Broadway, Baltimore, MD 21205, United States; Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, 624 N. Broadway, Baltimore, MD 21205, United States.
Abstract
BACKGROUND: Prescription opioid use disorder and overdose have risen substantially in the U.S. Primary care physicians are critical to many ongoing and proposed efforts to address the prescription opioid epidemic. Yet, little is known about their attitudes and beliefs surrounding this issue. This study aimed to determine primary care physicians' perceptions of the seriousness of the problem, its causes, groups responsible for addressing it, attitudes toward individuals with prescription opioid use disorder, beliefs about the effectiveness of addiction treatments, and support for various policies. METHODS: We conducted a national web-based survey in 2014 among 1010 primary care physicians. We gauged responses to attitude and belief items on 7-point Likert scales. We examined the proportion agreeing with each statement, and whether responses differed among physicians prescribing higher and lower volumes of opioids. RESULTS: Respondents largely attributed the causes of prescription opioid use disorder to individual-oriented factors and certain physician-oriented factors, and believed that individuals with prescription opioid use disorder and physicians were primarily responsible for addressing the problem. Negative attitudes toward people with prescription opioid use disorder were prevalent, but a majority believed that treatment could be effective. There was majority support for all measured policies, with the highest levels of support for policies to monitor prescribing among patients potentially at risk for an opioid use disorder and to improve physician education and training. CONCLUSIONS: Given strong endorsement of recommended policies, physician support could be leveraged to advance efforts to curb prescription opioid use disorder and overdose.
BACKGROUND: Prescription opioid use disorder and overdose have risen substantially in the U.S. Primary care physicians are critical to many ongoing and proposed efforts to address the prescription opioid epidemic. Yet, little is known about their attitudes and beliefs surrounding this issue. This study aimed to determine primary care physicians' perceptions of the seriousness of the problem, its causes, groups responsible for addressing it, attitudes toward individuals with prescription opioid use disorder, beliefs about the effectiveness of addiction treatments, and support for various policies. METHODS: We conducted a national web-based survey in 2014 among 1010 primary care physicians. We gauged responses to attitude and belief items on 7-point Likert scales. We examined the proportion agreeing with each statement, and whether responses differed among physicians prescribing higher and lower volumes of opioids. RESULTS: Respondents largely attributed the causes of prescription opioid use disorder to individual-oriented factors and certain physician-oriented factors, and believed that individuals with prescription opioid use disorder and physicians were primarily responsible for addressing the problem. Negative attitudes toward people with prescription opioid use disorder were prevalent, but a majority believed that treatment could be effective. There was majority support for all measured policies, with the highest levels of support for policies to monitor prescribing among patients potentially at risk for an opioid use disorder and to improve physician education and training. CONCLUSIONS: Given strong endorsement of recommended policies, physician support could be leveraged to advance efforts to curb prescription opioid use disorder and overdose.
Authors: David A Fiellin; Richard S Schottenfeld; Christopher J Cutter; Brent A Moore; Declan T Barry; Patrick G O'Connor Journal: JAMA Intern Med Date: 2014-12 Impact factor: 21.873
Authors: Bernice A Pescosolido; Jack K Martin; J Scott Long; Tait R Medina; Jo C Phelan; Bruce G Link Journal: Am J Psychiatry Date: 2010-09-15 Impact factor: 18.112
Authors: Linda LeResche; Kathleen Saunders; Sascha Dublin; Stephen Thielke; Joseph O Merrill; Susan M Shortreed; Cynthia Campbell; Michael R Von Korff Journal: J Womens Health (Larchmt) Date: 2015-07-08 Impact factor: 2.681
Authors: Marcus A Bachhuber; Emma E McGinty; Alene Kennedy-Hendricks; Jeff Niederdeppe; Colleen L Barry Journal: PLoS One Date: 2015-07-01 Impact factor: 3.240
Authors: Rose A Rudd; Len J Paulozzi; Michael J Bauer; Richard W Burleson; Rick E Carlson; Dan Dao; James W Davis; Jennifer Dudek; Beth Ann Eichler; Jessie C Fernandes; Anna Fondario; Barbara Gabella; Beth Hume; Theron Huntamer; Mbabazi Kariisa; Thomas W Largo; JoAnne Miles; Ashley Newmyer; Daniela Nitcheva; Beatriz E Perez; Scott K Proescholdbell; Jennifer C Sabel; Jessica Skiba; Svetla Slavova; Kathy Stone; John M Tharp; Tracy Wendling; Dagan Wright; Anne M Zehner Journal: MMWR Morb Mortal Wkly Rep Date: 2014-10-03 Impact factor: 17.586
Authors: Audrey L Jones; Stefan G Kertesz; Leslie R M Hausmann; Maria K Mor; Ying Suo; Warren B P Pettey; James H Schaefer; Adi V Gundlapalli; Adam J Gordon Journal: J Subst Abuse Treat Date: 2020-02-29
Authors: Felicia R Bixler; Thomas R Radomski; Susan L Zickmund; KatieLynn M Roman; Leslie R M Hausmann; Carolyn T Thorpe; Jennifer A Hale; Florentina E Sileanu; Walid F Gellad Journal: J Opioid Manag Date: 2019 May/Jun
Authors: Ju Nyeong Park; Saba Rouhani; Leo Beletsky; Louise Vincent; Brendan Saloner; Susan G Sherman Journal: Milbank Q Date: 2020-08-18 Impact factor: 4.911
Authors: Elizabeth M Stone; Alene Kennedy-Hendricks; Colleen L Barry; Marcus A Bachhuber; Emma E McGinty Journal: Drug Alcohol Depend Date: 2021-02-16 Impact factor: 4.492
Authors: Jennifer D Ellis; Jami L Mayo; Charlene E Gamaldo; Patrick H Finan; Andrew S Huhn Journal: J Clin Sleep Med Date: 2022-02-01 Impact factor: 4.062